Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial
PaperCitations, authors & open-access status
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 470 citations, 2016 year and green oa status.
470
Citations
2016
Year
green
OA Status